JP2016539935A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016539935A5 JP2016539935A5 JP2016529439A JP2016529439A JP2016539935A5 JP 2016539935 A5 JP2016539935 A5 JP 2016539935A5 JP 2016529439 A JP2016529439 A JP 2016529439A JP 2016529439 A JP2016529439 A JP 2016529439A JP 2016539935 A5 JP2016539935 A5 JP 2016539935A5
- Authority
- JP
- Japan
- Prior art keywords
- agent
- agent according
- animal
- anaplerotic
- animals
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361904365P | 2013-11-14 | 2013-11-14 | |
| US61/904,365 | 2013-11-14 | ||
| PCT/US2014/065670 WO2015073803A1 (en) | 2013-11-14 | 2014-11-14 | Neurodegenerative disorders and methods of treatment and diagnosis thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019167372A Division JP2020063233A (ja) | 2013-11-14 | 2019-09-13 | 神経変性障害、ならびにその治療及び診断法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016539935A JP2016539935A (ja) | 2016-12-22 |
| JP2016539935A5 true JP2016539935A5 (https=) | 2017-12-21 |
| JP6588903B2 JP6588903B2 (ja) | 2019-10-09 |
Family
ID=53058060
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016529439A Expired - Fee Related JP6588903B2 (ja) | 2013-11-14 | 2014-11-14 | 神経変性障害、ならびにその治療及び診断法 |
| JP2019167372A Pending JP2020063233A (ja) | 2013-11-14 | 2019-09-13 | 神経変性障害、ならびにその治療及び診断法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019167372A Pending JP2020063233A (ja) | 2013-11-14 | 2019-09-13 | 神経変性障害、ならびにその治療及び診断法 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US9833430B2 (https=) |
| EP (2) | EP3068492B1 (https=) |
| JP (2) | JP6588903B2 (https=) |
| AU (1) | AU2014348457B2 (https=) |
| CA (1) | CA2929601A1 (https=) |
| ES (1) | ES2774321T3 (https=) |
| WO (1) | WO2015073803A1 (https=) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1929995A1 (en) | 2006-12-04 | 2008-06-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Anaplerotic therapy of Huntington disease and other polyglutamine diseases |
| CA2894456C (en) | 2012-12-13 | 2022-06-28 | Baylor Research Institute | Triheptanoin for the treatment of glucose transporter 1 deficiency |
| ES2774321T3 (es) | 2013-11-14 | 2020-07-20 | Univ Queensland | Trastornos neurodegenerativos y métodos de tratamiento y diagnóstico de los mismos |
| US12599579B2 (en) | 2016-04-19 | 2026-04-14 | Axcess Global Sciences, Llc | Compositions and compounds containing ketone bodies and/or ketone body precursors and one or more amino acids |
| US12109182B2 (en) | 2016-04-19 | 2024-10-08 | Axcess Global Sciences, Llc | Administration of R-beta-hydroxybutyrate and related compounds in humans |
| US20230346721A1 (en) | 2018-04-18 | 2023-11-02 | Axcess Global Sciences, Llc | Beta-hydroxybutyric acid compositions and methods for delivery of ketone bodies |
| US12533346B2 (en) | 2016-04-19 | 2026-01-27 | Axcess Global Sciences, Llc | Administration of berberine metabolites |
| US11944598B2 (en) | 2017-12-19 | 2024-04-02 | Axcess Global Sciences, Llc | Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer |
| US12329734B2 (en) | 2017-12-19 | 2025-06-17 | Axcess Global Sciences, Llc | Use of S-beta-hydroxybutyrate compounds for induction and maintenance of flow |
| US12521378B2 (en) | 2016-04-19 | 2026-01-13 | Axcess Global Sciences, Llc | Administration of R-beta-hydroxybutyrate salt blend and related compounds in humans |
| US12496283B2 (en) | 2016-04-19 | 2025-12-16 | Axcess Global Sciences, Llc | Administration of R-beta-hydroxybutyrate and related compounds in humans |
| US10925843B2 (en) | 2018-04-18 | 2021-02-23 | Axcess Global Sciences, Llc | Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate |
| WO2017208217A2 (en) * | 2016-06-01 | 2017-12-07 | Aspi Ip Holder Llc | C5 ketone compositions, and related methods, for therapeutic and performance supplementation |
| MX2018015188A (es) | 2016-06-08 | 2019-08-21 | Sunregen Healthcare Ag | Lipidos con un numero impar de atomos de carbono y su uso como una composicion farmaceutica o como un suplemento nutricional. |
| BR112020004023A2 (pt) * | 2017-09-12 | 2020-09-08 | Sunregen Healthcare Ag | uso de um composto e composição farmacêutica ou suplemento nutricional |
| US12090129B2 (en) | 2017-11-22 | 2024-09-17 | Axcess Global Sciences, Llc | Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use |
| US12472200B2 (en) | 2019-05-15 | 2025-11-18 | Axcess Global Sciences, Llc | Autobiotic compositions and method for promoting healthy gut microbiome |
| US11969430B1 (en) | 2023-03-10 | 2024-04-30 | Axcess Global Sciences, Llc | Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance |
| US12167993B2 (en) | 2019-06-21 | 2024-12-17 | Axcess Global Sciences, Llc | Non-vasoconstricting energy-promoting compositions containing ketone bodies |
| US12186297B2 (en) | 2020-08-26 | 2025-01-07 | Axcess Global Sciences, Llc | Compositions and methods for increasing lean-to-fat mass ratio |
| CN113917034A (zh) * | 2021-10-19 | 2022-01-11 | 北京豪思生物科技有限公司 | 用于评估阿尔茨海默症的生物标记组合及其应用和试剂盒 |
| WO2024155950A2 (en) * | 2023-01-20 | 2024-07-25 | Keto Innovations, Llc | C5 ketone compositions and related methods for therapeutic and performance supplementation |
| WO2025184834A1 (zh) * | 2024-03-06 | 2025-09-12 | 中国科学院昆明动物研究所 | 一种庚酸酯化合物及其用于制备预防和/或治疗神经退行性疾病的药物或功能食品中的用途 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4025649A (en) | 1974-08-19 | 1977-05-24 | Labaz | Acetic acid derivatives having pharmacological activity and compositions containing the same |
| DE3032300A1 (de) | 1980-08-27 | 1982-04-01 | Alfred Ing. Wien Lohninger | Mittel zur parenteralen ernaehrung |
| GB2104079B (en) | 1981-08-14 | 1985-08-21 | London Polytech | New aminoacid isomers, their production and their medicinal use |
| US4753963A (en) | 1985-09-26 | 1988-06-28 | The Procter & Gamble Company | Nutritional fat suitable for enteral and parenteral products |
| JP3486778B2 (ja) | 1993-04-02 | 2004-01-13 | 三菱ウェルファーマ株式会社 | アルツハイマー病予防治療剤 |
| US20090253781A1 (en) | 2002-05-24 | 2009-10-08 | Btg International Limited | Therapeutic compositions |
| US6740679B1 (en) | 1999-02-05 | 2004-05-25 | Baylor University Medical Center | Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid |
| WO2000045649A1 (en) | 1999-02-05 | 2000-08-10 | Baylor University Medical Center | Nutritional supplement or pharmaceutical preparation comprising triglycerides with seven-carbon fatty acid |
| JP2003513039A (ja) | 1999-11-03 | 2003-04-08 | ジュヴェノン インコーポレイテッド | 良性の健忘症を治療する方法 |
| US8124589B2 (en) | 2000-05-01 | 2012-02-28 | Accera, Inc. | Use of ketogenic compounds for treatment of age-associated memory impairment |
| US20020006959A1 (en) | 2000-05-01 | 2002-01-17 | Henderson Samuel T. | Use of medium chain triglycerides for the treatment and prevention of Alzheimer's Disease and other diseases resulting from reduced Neuronal Metabolism |
| US6835750B1 (en) | 2000-05-01 | 2004-12-28 | Accera, Inc. | Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II |
| EP1605950A4 (en) | 2003-03-06 | 2008-01-09 | Accera Inc | NOVEL CHEMICAL ENTITIES AND METHODS OF USE IN THE TREATMENT OF METABOLIC DISORDERS |
| US8399515B2 (en) | 2003-05-20 | 2013-03-19 | Baylor Research Institute | Five and fifteen carbon fatty acids for treating metabolic disorders and as nutritional supplements |
| EP1773317A4 (en) | 2004-07-02 | 2012-10-03 | Baylor Res Inst | METHOD OF TREATING OVERLOADING DISEASE DUE TO ACCUMULATION OF GLYCOGENES OR POLYSACCHARIDES |
| US7884115B2 (en) | 2004-09-28 | 2011-02-08 | Allergan, Inc. | Methods and compositions for the treatment of pain and other neurological conditions |
| CA2700431A1 (en) | 2006-09-26 | 2008-04-03 | Baylor Research Institute | Use of odd-chain fatty acids in the modulation of cellular catabolism |
| EP1929995A1 (en) | 2006-12-04 | 2008-06-11 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Anaplerotic therapy of Huntington disease and other polyglutamine diseases |
| KR101335021B1 (ko) | 2007-07-31 | 2013-12-12 | 액세라인크 | 게놈 테스트의 용도 및 인지 기능 저하 치료용 케톤성 화합물 |
| WO2009124250A1 (en) | 2008-04-03 | 2009-10-08 | The Trustees Of The University Of Pennsylvania | Compositions and methods for detecting tricarboxylic acid (tca) metabolic flux |
| KR20120129898A (ko) | 2009-12-30 | 2012-11-28 | 베일러 리서치 인스티튜트 | 알츠하이머 질환 및 노화 뇌를 위한 보충대사 치료요법 |
| US20110301238A1 (en) * | 2010-06-02 | 2011-12-08 | Borges Karin | Seizure related disorders and therapeutic methods thereof |
| JP2013528648A (ja) * | 2010-06-14 | 2013-07-11 | ベイラー リサーチ インスティテュート | 成人ポリグルコサン小体病（ａｐｂｄ）を処置するためのトリヘプタノイン食 |
| PH12022550598A1 (en) | 2010-12-23 | 2024-03-11 | Amazentis Sa | Compositions and methods for improving mitochondrial function and treating neurodenegenerative diseases and cognitive disorders |
| EP2599482A1 (en) * | 2011-11-30 | 2013-06-05 | Lunamed AG | Low dose therapeutic use of glyceryl tri-(4-phenylbutyrate) |
| CA2894456C (en) | 2012-12-13 | 2022-06-28 | Baylor Research Institute | Triheptanoin for the treatment of glucose transporter 1 deficiency |
| ES2774321T3 (es) | 2013-11-14 | 2020-07-20 | Univ Queensland | Trastornos neurodegenerativos y métodos de tratamiento y diagnóstico de los mismos |
-
2014
- 2014-11-14 ES ES14861265T patent/ES2774321T3/es active Active
- 2014-11-14 US US15/036,523 patent/US9833430B2/en not_active Expired - Fee Related
- 2014-11-14 EP EP14861265.8A patent/EP3068492B1/en active Active
- 2014-11-14 AU AU2014348457A patent/AU2014348457B2/en not_active Ceased
- 2014-11-14 JP JP2016529439A patent/JP6588903B2/ja not_active Expired - Fee Related
- 2014-11-14 CA CA2929601A patent/CA2929601A1/en not_active Abandoned
- 2014-11-14 EP EP20150222.6A patent/EP3689343A1/en not_active Withdrawn
- 2014-11-14 WO PCT/US2014/065670 patent/WO2015073803A1/en not_active Ceased
-
2017
- 2017-11-29 US US15/825,572 patent/US20180207121A1/en not_active Abandoned
-
2018
- 2018-10-25 US US16/171,191 patent/US20190255008A1/en not_active Abandoned
-
2019
- 2019-09-13 JP JP2019167372A patent/JP2020063233A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016539935A5 (https=) | ||
| JP2016503793A5 (https=) | ||
| JP2015514135A5 (https=) | ||
| JP2014517008A5 (https=) | ||
| EP2660241A3 (en) | C-17-heteroaryl steroidal compounds as inhibitors of cyp11b, cyp17, and/or cyp21 | |
| JP2012097105A5 (https=) | ||
| EP2552203A4 (en) | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF VIRUS INFECTIONS | |
| JP2016511753A5 (https=) | ||
| IL221764A (en) | Use of bile acid sulfate to make pharmaceutical preparations for the treatment of fxr-related diseases | |
| JP2019516739A5 (https=) | ||
| JP2018517666A5 (https=) | ||
| MY189770A (en) | Biaryl derivative as gpr120 agonists | |
| HRP20210999T1 (hr) | Derivati tirozina i pripravci koji ih sadrže | |
| RU2018136872A (ru) | Композиции, содержащие 15-oh эпк, и способы их применения | |
| JP2011046708A5 (https=) | ||
| JP2017505785A5 (https=) | ||
| JP2012520888A5 (https=) | ||
| EP2107870A4 (en) | IMPROVED KLISTIER WITH REDUCED REIZEFFECT FOR THE TREATMENT OF INFLAMMABLE DARMER DISEASES | |
| JP2018537513A5 (https=) | ||
| JP2017505809A5 (https=) | ||
| JP2016501249A5 (https=) | ||
| JP2016501248A5 (https=) | ||
| WO2010094734A3 (en) | Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation | |
| JP2013523623A5 (https=) | ||
| EP2321265A4 (en) | INOSIT- AND TREHALOSEDERIVATES AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES CONTAINING THEM |